Cargando…
Eosinophilic Annular Erythema due to Certolizumab Pegol Therapy for Rheumatoid Arthritis Post-COVID-19 Vaccine
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Mattioli 1885
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10188144/ https://www.ncbi.nlm.nih.gov/pubmed/37196288 http://dx.doi.org/10.5826/dpc.1302a95 |
| _version_ | 1785042852964728832 |
|---|---|
| author | Bassi, Andrea Piccolo, Vincenzo Ginori, Alessandro Galippi, Grazia Mazzatenta, Carlo |
| author_facet | Bassi, Andrea Piccolo, Vincenzo Ginori, Alessandro Galippi, Grazia Mazzatenta, Carlo |
| author_sort | Bassi, Andrea |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10188144 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Mattioli 1885 |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-101881442023-05-17 Eosinophilic Annular Erythema due to Certolizumab Pegol Therapy for Rheumatoid Arthritis Post-COVID-19 Vaccine Bassi, Andrea Piccolo, Vincenzo Ginori, Alessandro Galippi, Grazia Mazzatenta, Carlo Dermatol Pract Concept Research Letter Mattioli 1885 2023-04-01 /pmc/articles/PMC10188144/ /pubmed/37196288 http://dx.doi.org/10.5826/dpc.1302a95 Text en ©2023 Bassi et al. https://creativecommons.org/licenses/by-nc/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (BY-NC-4.0), https://creativecommons.org/licenses/by-nc/4.0/, which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original authors and source are credited. |
| spellingShingle | Research Letter Bassi, Andrea Piccolo, Vincenzo Ginori, Alessandro Galippi, Grazia Mazzatenta, Carlo Eosinophilic Annular Erythema due to Certolizumab Pegol Therapy for Rheumatoid Arthritis Post-COVID-19 Vaccine |
| title | Eosinophilic Annular Erythema due to Certolizumab Pegol Therapy for Rheumatoid Arthritis Post-COVID-19 Vaccine |
| title_full | Eosinophilic Annular Erythema due to Certolizumab Pegol Therapy for Rheumatoid Arthritis Post-COVID-19 Vaccine |
| title_fullStr | Eosinophilic Annular Erythema due to Certolizumab Pegol Therapy for Rheumatoid Arthritis Post-COVID-19 Vaccine |
| title_full_unstemmed | Eosinophilic Annular Erythema due to Certolizumab Pegol Therapy for Rheumatoid Arthritis Post-COVID-19 Vaccine |
| title_short | Eosinophilic Annular Erythema due to Certolizumab Pegol Therapy for Rheumatoid Arthritis Post-COVID-19 Vaccine |
| title_sort | eosinophilic annular erythema due to certolizumab pegol therapy for rheumatoid arthritis post-covid-19 vaccine |
| topic | Research Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10188144/ https://www.ncbi.nlm.nih.gov/pubmed/37196288 http://dx.doi.org/10.5826/dpc.1302a95 |
| work_keys_str_mv | AT bassiandrea eosinophilicannularerythemaduetocertolizumabpegoltherapyforrheumatoidarthritispostcovid19vaccine AT piccolovincenzo eosinophilicannularerythemaduetocertolizumabpegoltherapyforrheumatoidarthritispostcovid19vaccine AT ginorialessandro eosinophilicannularerythemaduetocertolizumabpegoltherapyforrheumatoidarthritispostcovid19vaccine AT galippigrazia eosinophilicannularerythemaduetocertolizumabpegoltherapyforrheumatoidarthritispostcovid19vaccine AT mazzatentacarlo eosinophilicannularerythemaduetocertolizumabpegoltherapyforrheumatoidarthritispostcovid19vaccine |